Feed / OCUL

Ocular Therapeutix, Inc.

OCUL

Healthcare · 10.87 +0.8% today

Isolated · not yet confirmedMarket checked 25 Aug, 15:55 GMT-4

Jodie situation report

Ocular Therapeutix, Inc.'s current read is isolated; its market group is not confirming.

No new filing conclusion is available. 0 of 18 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 3 directly disclosed connections are confirming.

Company+0.8% todayVolume comparison unavailable
Market group0 of 18 activeBiotech and Energy · unavailable
Disclosed network0 of 3 confirmingNo filing-linked name is confirming now
What would change this read
  • OCUL's market-adjusted activity becomes unusual and at least one connected name confirms.

Invalidation: The isolated read changes if OCUL's group or a disclosed connection begins moving with it.

Watch this read

Who this business touches

The relationships behind OCUL

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

JEFJefferies Financial Group Inc.partnerNov 4, 2025

In August 2021, we entered into an Open Market Sale Agreement, or the 2021 Sales Agreement, with Jefferies LLC, or Jefferies, under which we may offer and sell shares of our common stock from time to time through Jefferies, acting as agent.

JEFJefferies Financial Group Inc.lenderMay 5, 2026

In August 2021, we entered into an Open Market Sale Agreement, or the 2021 Sales Agreement, with Jefferies LLC, or Jefferies, under which we may offer and sell shares of our common stock from time to time through Jefferies, acting as agent.

Depended on by

FDMT4D Molecular Therapeutics, Inc.competitorMar 18, 2026

We also face competition from late-stage sustained release VEGF receptor tyrosine kinase 11 inhibitor programs at EyePoint Inc.

Filing peers

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 3 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

OCUL is currently a Follower in the organic co-movement group Biotech and Energy. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

This group is retained as the last observed read for OCUL; it is not active in the latest market snapshot.